申请人:SmithKline Corporation
公开号:US04086350A1
公开(公告)日:1978-04-25
Tricyclic piperidylidene derivatives administered internally to an animal host, in therapeutically effective amounts, produce antipsychotic activity without extrapyramidal symptoms. Certain of the active ingredients are novel compounds per se.
三环哌啶基衍生物在动物宿主内部以治疗有效剂量给药,能产生抗精神病活性,而不会出现锥体外症状。其中一些活性成分是新颖的化合物本身。